__NUXT_JSONP__("/drugs/Immunocytokine_NHS-IL2-LT", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"A fusion protein consisting of a mouse-human chimeric antibody directed against DNA released by necrotic tumor cells fused to two molecules of a genetically modified human interleukin-2 (IL-2) with potential antineoplastic activity. Upon administration, the antibody moiety of immunocytokine NHS-IL2-LT binds to DNA released by necrotic tumor cells located primarily at the core of necrotic solid tumors, delivering the IL-2 moiety. In turn, the IL-2 moiety of this agent activates the immune system to mount a cytotoxic T lymphocyte response against nearby tumor cells.",fdaUniiCode:"EI74F49ZLJ",identifier:"C82411",preferredName:c,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C1512"],synonyms:["Ch.14.18-IL2","EMD 521873",c,"SELECTIKINE","Selectikine"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FImmunocytokine_NHS-IL2-LT",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","Immunocytokine_NHS-IL2-LT","Immunocytokine NHS-IL2-LT","2021-10-30T13:46:00.043Z")));